Publication:
Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

Simple item page
dc.contributor.authorsErcelep, O.; Telli, T.; Alan, O.; Hasanov, R.; Simsek, E.; Halil, S.; Ozturk, M.; Babacan, N.; Kaya, S.; Kaya, H.; Dane, F.; Yumuk, P.
dc.date.accessioned2022-03-10T17:55:45Z
dc.date.accessioned2026-01-10T18:43:39Z
dc.date.available2022-03-10T17:55:45Z
dc.date.issued2017
dc.identifier.doidoiWOS:000463860801272
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://hdl.handle.net/11424/221930
dc.identifier.wosWOS:000463860801272
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectmetastatic non-small cell lung cancer
dc.subjectEGFRTKI
dc.subjectsmoking
dc.titleSmokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS1965
oaire.citation.issue11
oaire.citation.startPageS1965
oaire.citation.titleJOURNAL OF THORACIC ONCOLOGY
oaire.citation.volume12

Files

Collections

Araştırma Çıktıları